Ultrasound-mediated targeted drug delivery in cancer patients – fact or fiction?
Despite considerable global investment towards prevention and improving outcomes, cancer remains a leading cause of morbidity and mortality worldwide; as recently as 2010, only a modest decrease (-13.8%) in standardised death rates due to cancer have been observed since 1990. In 2009 cancer cost the European Union $126 billon in healthcare cost and productivity losses […]
Paul Lyon, Prateek Katti
Institute of Biomedical Engineering, University of Oxford